The Patent Finder

Method and Apparatus for Catheter-Based Extracorporeal Membrane Oxygenation (ECMO)

Vantis Vascular, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 18/484,398, filed Oct 10, 2023. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,964,091Method and Apparatus for Catheter-Based Extracorporeal Membrane Oxygenation (ECMO)
In force
 · High confidence
Vantis Vascular, Inc.In force
High confidence
US 12,226,564Method and Apparatus for Catheter-Based Extracorporeal Membrane Oxygenation (ECMO)
In force
 · High confidence
Vantis Vascular, Inc.In force
High confidence
US 12,390,572Method and Apparatus for Catheter-Based Extracorporeal Membrane Oxygenation (ECMO)
In force
 · High confidence
Vantis Vascular, Inc.In force
High confidence
US 12,569,608Catheter-Based Extracorporeal Membrane Oxygenation (ECMO)
In force
 · Medium confidence
Vantis Vascular, Inc.In force
Medium confidence
Application 19/056,723Method and Apparatus for Catheter-Based Extracorporeal Membrane Oxygenation (ECMO)
Pending
Not granted
Vantis Vascular, Inc.PendingNot granted
Application 19/303,322Method and Apparatus for Catheter-Based Extracorporeal Membrane Oxygenation (ECMO)
Pending
Not granted
Vantis Vascular, Inc.PendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Vantis Vascular, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited